[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
May 20, 2009

Escitalopram Treatment of Generalized Anxiety Disorder in Older Adults

JAMA. 2009;301(19):1987-1988. doi:10.1001/jama.2009.651

To the Editor: We have some concerns regarding the randomized controlled trial by Dr Lenze and colleagues,1 which investigated the efficacy of escitalopram for the treatment of generalized anxiety disorder (GAD) in older adults. First, it is not clear why the primary efficacy analysis was based on the Clinical Global Impression-Improvement scale. Patients were included based on a cutoff score on the Hamilton Anxiety Rating Scale, and change in score on this more specific scale is usually recommended as the primary outcome measure in studies of GAD.2 Also, only weekly change in the Hamilton Anxiety Rating Scale was presented as a secondary outcome measure. Overall change from baseline to end point would have facilitated the interpretation of the results.

First Page Preview View Large
First page PDF preview
First page PDF preview
×